GlassScriptPhysician profile
Letty M Villa
NPI 1316057763
$654.93
in general payments reported to CMS, 2019-2025
10 companies · $90.00 in 2025
The $90.00 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $63.06 · 2021: $22.71 · 2022: $11.87 · 2023: $147 · 2024: $28.73 · 2025: $90.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.91 |
| Education | $109.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $134.04 | 2019-2020 | |
| Coopersurgical, INC. | $128.18 | 2023 | Summit Doppler |
| Abbvie INC. | $94.28 | 2019-2022 | |
| Millicent US INC | $90.00 | 2025 | |
| Pfizer INC. | $61.25 | 2019-2023 | |
| Hologic Sales and Service, LLC | $45.85 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Amag Pharmaceuticals, INC. | $31.32 | 2019-2020 | |
| Therapeuticsmd, INC. | $29.64 | 2019 | |
| Ascend Therapeutics US, LLC | $28.80 | 2020-2021 | |
| Avion Pharmaceuticals | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Letty Villa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.